Anand Rathi Wealth Limited Disclosure of Shareholding Change

Anand Rathi Financial Services Limited, a promoter group entity, has disclosed a change in its shareholding in Anand Rathi Wealth Limited. The company sold 14,46,000 shares, representing 1.74% of the total share capital, through an open market transaction on May 29, 2026. Following this sale, Anand Rathi Financial Services Limited’s holding in Anand Rathi Wealth Limited has reduced to 1,50,88,758 shares, accounting for 18.17% of the total voting capital.

Shareholding Disclosure Filed

Anand Rathi Financial Services Limited has submitted a disclosure regarding its shareholding in Anand Rathi Wealth Limited, as per SEBI regulations. This filing details a recent transaction involving the company’s stake in its promoter group entity.

Transaction Details

The disclosure states that Anand Rathi Financial Services Limited has undertaken a sale of shares in Anand Rathi Wealth Limited. The transaction involved 14,46,000 shares being sold. This quantity represents 1.74% of the total share capital of Anand Rathi Wealth Limited. The sale was executed through an open market transaction on May 29, 2026.

Updated Shareholding

Prior to this sale, Anand Rathi Financial Services Limited held 1,65,34,758 shares, which constituted 19.92% of the total share capital. Following the disposal of 14,46,000 shares, the entity’s holding in Anand Rathi Wealth Limited has been adjusted. The current holding stands at 1,50,88,758 shares, representing 18.17% of the total voting capital. The total diluted share/voting capital of Anand Rathi Wealth Limited after the acquisition/sale is 8,42,60,634.

Regulatory Compliance

The disclosure adheres to Regulation 29(2) of the SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011. The equity share capital and total voting capital of Anand Rathi Wealth Limited remained unchanged at 8,30,20,634 both before and after the reported transaction.

Source: BSE

Previous Article

Anand Rathi Financial Services Limited Disclosure on Share Encumbrance

Next Article

Mankind Pharma Limited Acquires Remaining 10% Stake in Upakarma Ayurveda